Filing Details
- Accession Number:
- 0001209191-16-110187
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-23 14:15:04
- Reporting Period:
- 2016-03-23
- Filing Date:
- 2016-03-23
- Accepted Time:
- 2016-03-23 14:15:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1616543 | Senseonics Holdings Inc. | SENS | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1255743 | J James Bochnowski | C/O Delphi Ventures 160 Bovet Road, Suite 408 San Mateo CA 94402 | No | No | Yes | No | |
1270734 | Deepika Pakianathan | C/O Delphi Ventures 160 Bovet Road, Suite 408 San Mateo CA 94402 | No | No | Yes | No | |
1270735 | A Douglas Roeder | C/O Delphi Ventures 160 Bovet Road, Suite 408 San Mateo CA 94402 | Yes | No | Yes | No | |
1271389 | L David Douglass | C/O Delphi Ventures 160 Bovet Road, Suite 408 San Mateo CA 94402 | No | No | Yes | No | |
1436285 | Delphi Ventures Viii Lp | 160 Bovet Road, Suite 408 San Mateo CA 94402 | No | No | Yes | No | |
1451526 | Delphi Bioinvestments Viii Lp | 160 Bovet Road, Suite 408 San Mateo CA 94402 | No | No | Yes | No | |
1457494 | Delphi Management Partners Viii, L.l.c. | C/O Delphi Ventures 160 Bovet Road, Suite 408 San Mateo CA 94402 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-23 | 1,216,195 | $2.85 | 11,237,221 | No | 4 | P | Indirect | Delphi Ventures VIII, L.P. |
Common Stock | Acquisiton | 2016-03-23 | 11,875 | $2.85 | 109,725 | No | 4 | P | Indirect | Delphi BioInvestments VIII, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Delphi Ventures VIII, L.P. |
No | 4 | P | Indirect | Delphi BioInvestments VIII, L.P. |
Footnotes
- The reported securities are directly owned by Delphi Ventures VIII, L.P. ("DV VIII"). Delphi Management Partners VIII, L.L.C. ("DMP VIII") is the general partner of DV VIII and may be deemed to have sole voting and dispositive power over the securities held by DV VIII. Douglas A. Roeder, James J. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of DMP VIII and may be deemed to share voting and dispositive power over the securities held by DV VIII. Such persons and entities disclaim beneficial ownership of the securities held by DV VIII, except to the extent of any pecuniary interest therein.
- The reported securities are directly owned by Delphi BioInvestments VIII, L.P. ("DBI VIII"). DMP VIII is the general partner of DBI VIII and may be deemed to have sole voting and dispositive power over the securities held by DBI VIII. Douglas A. Roeder, James J. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of DMP VIII and may be deemed to share voting and dispositive power over the securities held by DBI VIII. Such persons and entities disclaim beneficial ownership of the securities held by DBI VIII, except to the extent of any pecuniary interest therein.